Followers | 46 |
Posts | 7114 |
Boards Moderated | 0 |
Alias Born | 07/18/2020 |
Tuesday, January 16, 2024 4:03:08 PM
"Second, Fannie revealed that through September 30, 2023, the annual cost of its CRT programs had reached an all-time high of nearly $1.5 billion, while the lifetime expected value of its “freestanding credit enhancement receivables” had fallen to just $265 million, compared with $565 million at the end of 2022. And finally, despite a $4.7 billion increase in net worth in the third quarter, Fannie only was able to trim its capital deficit by $1.8 billion, because even with its total assets rising just 16 basis points its risk-weighted assets rose by 2.3 percent, likely caused by diminished capital credit given to its CRTs, due to the company’s taking more risk on recent issuances."
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM